U.S. Stock Market Today: Dow, S&P 500 and Nasdaq Mixed at Midday as Fed Rate Cut Looms

U.S. Stock Market Today: Dow, S&P 500 and Nasdaq Mixed at Midday as Fed Rate Cut Looms

U.S. stocks are treading water near record highs at midday Monday, December 8, 2025, as Wall Street kicks off a pivotal week dominated by the Federal Reserve’s next interest‑rate decision and a burst of blockbuster deal news.

By late morning in New York, the Dow Jones Industrial Average was modestly lower, while the S&P 500 was roughly flat and the Nasdaq Composite edged higher, reflecting a cautious “wait‑and‑see” mood rather than outright risk‑on or risk‑off positioning.  [1]

At the same time, traders are digesting a hostile takeover twist in Hollywood, a major AI data‑infrastructure acquisition by IBM, and sharp moves in biotech and semiconductor names that are driving much of today’s action beneath the surface.  [2]

All index levels and market moves below refer to trading late in the U.S. morning on December 8, 2025, and may change as the session continues.


Major U.S. indexes hover just below record highs

Midday performance

  • Dow Jones Industrial Average: down roughly 0.2%–0.3%, after falling about 124 points to 47,831.33 at around 9:44 a.m. ET.  [3]
  • S&P 500: essentially flat, up or down only a hair (around 0.0%), near 6,871.  [4]
  • Nasdaq Composite: up about 0.1%–0.3%, extending tech’s recent outperformance.  [5]

According to Investopedia’s live “Dow Jones Today” blog, all three major indexes entered Monday within striking distance of their all‑time closing highs—roughly 0.3% for the S&P 500, 0.6% for the Dow, and 1.6% for the Nasdaq—after back‑to‑back weekly gains.  [6]

Last Friday, a cooler‑than‑feared inflation report helped push U.S. equities higher and reinforced expectations that the Fed is about to cut rates again this week, leaving the market in a relatively optimistic yet finely balanced state as the new week begins.  [7]


Fed rate‑cut expectations dominate trading

The central story behind today’s muted headline moves is Wednesday’s Federal Reserve meeting, widely expected to deliver a 25‑basis‑point rate cut—the third in a row. Futures tracked by CME’s FedWatch tool now price roughly an 85%–90% probability that the Fed will lower its benchmark rate into the 3.5%–3.75% range.  [8]

What’s making this week especially sensitive is the possibility of an unusually split Fed:

  • A Reuters survey and commentary from market economists highlight the risk of a three‑way divide on the policy committee, with some officials favoring a larger 50‑bp cut, others preferring no change, and the majority leaning toward the quarter‑point move markets expect.  [9]
  • Analysts at Pepperstone and Deutsche Bank warn that if four or more policymakers dissent, it would be the largest split in Fed votes in decades, complicating the outlook for 2026’s path of cuts.  [10]

Global market coverage from Bloomberg and Fortune underscores the same theme: “everything is on hold” until the Fed delivers, with investors focused less on Wednesday’s cut—which is regarded as almost a done deal—and more on what Chair Jerome Powell signals about the pace of easing next year.  [11]

Rates, dollar and commodities at midday

Bond and currency markets reflect this tension:

  • The 10‑year U.S. Treasury yield has climbed to about 4.18%, from 4.14% at Friday’s close, nudging borrowing costs back toward their highest levels in more than a month.  [12]
  • The U.S. dollar index is modestly stronger near 99.1, while gold is slightly lower around $4,235 an ounce[13]
  • West Texas Intermediate crude oil is off about 1.5% near $59 a barrel, and Bitcoin is trading just below $91,500, up from overnight lows above $89,000.  [14]

The message: investors are cautiously positioning for a “hawkish cut”—a rate reduction accompanied by more conservative guidance on how many cuts to expect in 2026—rather than a dramatic pivot toward ultra‑loose policy.  [15]


Streaming mega‑deal battle shakes media stocks

One of the liveliest stories on the tape today is the Hollywood bidding war around Warner Bros. Discovery (WBD).

  • On Friday, Warner Bros. Discovery agreed to be acquired by Netflix in a deal valued at about $83 billion, a move that would dramatically reshape the global streaming landscape.  [16]
  • Over the weekend, Paramount Skydance (PSKY) countered with a hostile $108.4 billion bid for WBD, escalating the fight for one of Hollywood’s crown‑jewel content libraries.  [17]

That tug‑of‑war is driving some of the most eye‑catching moves in large‑cap media:

  • WBD shares are up roughly 6%–7% by late morning.  [18]
  • Paramount Skydance is up in the mid‑single digits, while
  • Netflix is down about 3%, as investors weigh the cost, leverage and regulatory risk of its own proposed deal.  [19]

Adding to the uncertainty, President Donald Trump said over the weekend that a combined Netflix–Warner Bros. Discovery could present a “big market share” problem, hinting at potential antitrust scrutiny if Netflix ultimately prevails.  [20]

Market analysts quoted across several outlets frame this as a textbook “event‑risk trade”: WBD shareholders are staring at rich takeover premiums, but the final outcome—and which bidder, if any, wins—will likely depend on both regulators and political pressure. Netflix holders, meanwhile, must decide whether the strategic upside justifies the increase in debt and integration complexity.  TechStock²+2TechStock²+2


AI data deal and chip headlines power tech leadership

Tech once again sits at the center of U.S. stock market action, thanks to a headline‑grabbing M&A deal in AI data infrastructure and new twists in the chip industry.

IBM–Confluent: $11 billion bet on AI “data plumbing”

IBM announced a definitive agreement to acquire Confluent (CFLT) for $31 per share in cash, valuing the streaming‑data specialist at about $11 billion, roughly a one‑third premium to its last close.  [21]

The deal sends:

  • Confluent stock up nearly 30%, making it one of the day’s biggest large‑cap winners.
  • IBM shares up around 1%–2%, as investors weigh the near‑term cash outlay against the promise of higher EBITDA and free cash flow once the acquisition closes in 2026.  TechStock²+2TechStock²+2

Strategically, IBM is pitching Confluent as a core piece of a “smart data platform” for enterprise generative AI—essential infrastructure to move and govern real‑time data streams that feed AI models. The deal continues IBM’s multi‑year pivot toward software and hybrid cloud, following previous acquisitions like Red Hat and HashiCorp.  TechStock²+1

Chipmakers: Broadcom headlines, Marvell hit, Nvidia still in focus

Semiconductors are another big story:

  • Broadcom (AVGO) is up around 2%–3% after reports that Microsoft is exploring custom AI chips with the company, a potential boost to Broadcom’s long‑term growth narrative.  [22]
  • Micron Technology (MU) is also higher, gaining more than 3% in early trade.  [23]
  • In contrast, Marvell Technology (MRVL) is among the early Nasdaq laggards, dropping roughly 8% after a downgrade from Benchmark and worries that Microsoft’s chip talks with Broadcom could erode Marvell’s strategic position.  [24]

TS2’s “Most Active Stocks Today” report highlights Nvidia, Tesla, Netflix, Warner Bros. Discovery, SoFi, IBM and Confluent among the busiest U.S. names, underscoring how AI, streaming consolidation and funding costs are the dominant themes on traders’ screens.  TechStock²

High‑growth names like Tesla and SoFi remain particularly sensitive to where the Fed ultimately steers interest rates in 2026, since their valuations are heavily tied to future earnings and the cost of capital.  TechStock²+1


Biotech breakouts lead biggest gainers list

Even as the major indexes turn in relatively modest moves, biotech is delivering some of Monday’s most dramatic gains.

  • Dyne Therapeutics (DYN) is surging after the company released much‑anticipated topline data from its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy (DMD). The results showed strong dystrophin production and encouraging early functional trends, sending the stock sharply higher on the session.  TechStock²
  • TS2’s “Biggest Stock Gainers Today” roundup lists Biodexa Pharmaceuticals (BDRX) and Immutep (IMMP)among small‑cap standouts, with intraday gains in the high‑20% to low‑30% range driven by pipeline updates and licensing deals.  TechStock²

Analysts stress that many of these biotech names remain high‑risk, high‑volatility plays: they often trade on binary trial outcomes, regulatory decisions and partnership news, leading to large daily swings in both directions.  TechStock²+1


Market breadth, sectors and valuations

Under the hood, Monday’s tape shows familiar 2025 patterns:

  • Tech and communication services are providing most of the leadership, thanks to the IBM–Confluent deal, semiconductor strength and the streaming battle around Warner Bros. Discovery.  [25]
  • The Dow’s underperformance versus the Nasdaq reflects weaker action in traditional industrial names relative to growth‑oriented tech.  [26]

From a valuation standpoint, a fresh Morningstar outlook for December 2025 estimates that the broad U.S. equity market is trading at roughly a 3% discount to the firm’s composite fair‑value estimate—hardly a screaming bargain, but not stretched either. The report argues that value and small‑cap stocks, which outperformed in November, still offer more upside than the mega‑cap growth leaders dominating this year’s headline indexes.  [27]

Global coverage from Reuters and Bloomberg describes a similar pattern overseas: global stocks are broadly flat, with investors in Europe and Asia also fixated on the Fed’s decision and the risk of a more hawkish tone on 2026 rate cuts.  [28]


Outlook: what Monday’s midday action signals for the week ahead

So what does today’s subdued, merger‑heavy session suggest about the rest of the week for the U.S. stock market?

  1. “Wait‑and‑see” mode is firmly in place.
    Bloomberg’s markets wrap notes that the S&P 500 is essentially churning near record highs, with Monday’s modest moves reflecting investors’ unwillingness to place big bets before the Fed speaks.  [29]
  2. Fed communication will matter more than the cut itself.
    Markets are broadly aligned on a 25‑bp cut; the real swing factor will be Powell’s press conference and the updated dot plot showing officials’ projections for growth, inflation and rates. A more hawkish trajectory for 2026 could pressure richly valued growth sectors, while a dovish surprise might extend the recent rally.  [30]
  3. Earnings and index changes will add stock‑specific volatility.
    The Economic Times highlights upcoming results from Oracle, Adobe, Broadcom and Costco later this week, which could spark sector‑specific moves in software, chips and retail.  [31]
    Investopedia also notes that Carvana, CRH and Comfort Systems USA are set to join the S&P 500 on December 22, a tailwind that’s already lifting those shares today.  [32]
  4. Seasonality still favors the bulls—but with caveats.
    Nasdaq’s recent market commentary points out that December is historically one of the most constructive months for U.S. stocks, and last week’s gains came as inflation pressures eased. At the same time, strategists warn that a “hawkish cut” or unexpectedly contentious Fed vote could trigger a bout of volatility before any year‑end rally resumes.  [33]

For now, Monday’s midday picture suggests a market caught between strong year‑end momentum and genuine macro uncertainty. Tech‑driven deal activity and biotech breakouts are providing excitement at the single‑stock level, but index‑level moves remain modest as Wall Street waits for the Fed to make its next move.

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.reuters.com, 5. www.reuters.com, 6. www.investopedia.com, 7. www.sharecafe.com.au, 8. www.reuters.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.swissinfo.ch, 12. www.investopedia.com, 13. www.investopedia.com, 14. www.investopedia.com, 15. www.swissinfo.ch, 16. www.investopedia.com, 17. www.reuters.com, 18. www.reuters.com, 19. m.economictimes.com, 20. www.investopedia.com, 21. www.reuters.com, 22. m.economictimes.com, 23. www.investopedia.com, 24. www.investopedia.com, 25. www.reuters.com, 26. m.economictimes.com, 27. global.morningstar.com, 28. www.reuters.com, 29. www.swissinfo.ch, 30. www.reuters.com, 31. m.economictimes.com, 32. www.investopedia.com, 33. www.nasdaq.com

Stock Market Today

  • Snowflake SNOW Stock Analysis: AI Momentum Meets Post-Earnings Sell-Off
    December 8, 2025, 11:55 AM EST. Snowflake (SNOW) delivered strong Q3 FY2026 results with 29% revenue growth and a raised full-year outlook, yet the stock slid ~11% on soft Q4 guidance. As of Dec 8, 2025, shares near $229, up ~70% YTD. Q3 revenue was $1.21B; product revenue rose 29% to $1.16B. Key metrics stayed healthy: NRR 125% and RPO $7.88B (+37%). AI momentum is evident in the AI Data Cloud with AI revenue at an annualized run rate of $100M. Investors focused on a decelerating Q4 guide (≈ 27% product revenue growth) and ongoing discounting on large deals. Valuation remains rich (forward P/E > 160x). Bulls point to AI-driven growth, bears wary of profitability and hyperscaler competition.
AI Stocks Today: Nvidia, Broadcom, Meta and New Robotics Bets Shape the 2026 AI Boom
Previous Story

AI Stocks Today: Nvidia, Broadcom, Meta and New Robotics Bets Shape the 2026 AI Boom

Merck (MRK) Stock Today – December 8, 2025: Pipeline Bets, Cidara Deal and Vaccine Policy Risks
Next Story

Merck (MRK) Stock Today – December 8, 2025: Pipeline Bets, Cidara Deal and Vaccine Policy Risks

Go toTop